Select Language:
A healthcare subsidiary of a major Chinese e-commerce platform has inaugurated its first permanent storefront dedicated solely to aesthetic medicine in Beijing’s central business district. Since beginning pre-sales last month, the new beauty clinic has received over 3,000 orders, and all appointment slots for the current month have been booked, according to recent reports.
The company has been gradually expanding into the aesthetic medicine sector over the past few years, increasing investments in physical locations and service offerings. It registered a trademark for its aesthetic branch earlier this year and launched its first company-operated clinic offering these services in Beijing’s Yizhuang Development Area this summer.
Industry experts note that the company’s vast online user base provides a significant advantage by attracting substantial traffic and potential clients through its digital platform. However, compared to well-known competitors like a popular platform and a major beauty service provider, this company’s aesthetic arm has seen limited visibility among female consumers interested in beauty treatments, and its market presence remains relatively modest.
In 2021, the company partnered with a publicly traded aesthetic medicine service provider operating physical clinics to develop an online consultation platform that offers personalized treatment plans and other services. While the company has managed to lower prices on some products due to its supply chain efficiencies, the cost of certain procedures remains relatively high, with some industry insiders pointing out that its pricing lacks a competitive edge.
The aesthetic medicine industry in the country remains fragmented, largely composed of small to medium-sized private clinics, with no dominant players emerging yet. This environment creates opportunities for new entrants. Nonetheless, establishing physical storefronts requires significant capital investment. From selecting locations and renovating spaces to hiring staff and managing ongoing operations, these efforts differ significantly from the company’s core online business model. Analysts caution that the impact of this new brick-and-mortar venture on the industry’s future remains uncertain.
As the user base for aesthetic treatments expands, there is increasing emphasis on safety and treatment efficacy. Practitioners highlight the growing need for drug traceability and transparent disclosure of doctor qualifications. These requirements call for major companies to help standardize industry practices and promote safer, more reliable services across the board.
ChatGPT
Perplexity
Gemini AI
Grok AI
